Key challenges faced for approval of anti-inflammatory drugs for asthma and COPD - European Medicines Agency perspective
Laura Fregonese (London, United Kingdom)
Source: Research Seminar 2022 – Pharmacology of asthma and COPD: current and future developments
Number: 7
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Laura Fregonese (London, United Kingdom). Key challenges faced for approval of anti-inflammatory drugs for asthma and COPD - European Medicines Agency perspective. Research Seminar 2022 – Pharmacology of asthma and COPD: current and future developments
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|